• Return to Headlines

Nektar Therapeut Down 17.3% Since SmarTrend Downtrend Call (NKTR)

By James Quinn

SmarTrend identified a Downtrend for Nektar Therapeut (NASDAQ:NKTR) on February 22nd, 2019 at $40.51. In approximately 2 months, Nektar Therapeut has returned 17.33% as of today's recent price of $33.49.

In the past 52 weeks, Nektar Therapeut share prices have been bracketed by a low of $29.22 and a high of $106.00 and are now at $33.57, 15% above that low price. The 200-day and 50-day moving averages have moved 0.47% lower and 1.22% lower over the past week, respectively.

Nektar Therapeutics, a research-based biopharmaceutical company, discovers and develops drug candidates for cancer, auto-immune disease, and chronic pain in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Nektar Therapeut.

Log in and add Nektar Therapeut (NKTR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights nektar therapeut

Ticker(s): NKTR